Teva and Sanofi-Aventis SA currently own on the market s best-selling drug Copaxone.

Teva and Sanofi-Aventis SA currently own on the market ‘s best-selling drug Copaxone, which had more than $ 2.8 billion in sales in 2009. Biogen Avonex also had more than $ 2 billion in annual revenues, while Bayer Betaseron and Merck’s Rebif had more than $ 1 billion in sales.

While many existing drugs through a daily injection or infusion should be administered, the medication side effects such as flu-like symptoms. The drugs orally taken Gilenya is used in Europe are prescribed at a 0.5-milligram daily dose to treat patients with highly active relapsing-remitting multiple sclerosis.With kind permission of can total daily Women’s Health Policy show Reports looking for in the archives of and sign up for mail for delivery this emphatically. To every day Women’s Health policy coverage is publish free service is National Partnership for Women & Families by The Advisory Board Company.